FGR and colorectal carcinoma: Analysis of TCGA indicated significantly higher TIDE prediction scores in CRC samples with the top 25% expressions of FGR or DKK1 compared to those in the bottom 25%, implying a diminished response to immunotherapy in these higher expressing groups (Fig. 8A) [27].